
How AI Will Change the ePrescribing Experience for Patients, Providers and Pharmacies
There are a number of important ways AI will impact patients, providers and pharmacies in the coming year. They break down into three key areas.
There are a number of important ways AI will impact patients, providers and pharmacies in the coming year. They break down into three key areas.
Through their alliance, Medisafe will deliver real-time interventions to help patients stay adherent and will alert Lash Group's clinicians when patients are considered "at-risk."
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
In some ways, it's a thinly veiled ad campaign for Nestlé's pre-surgery nutrition drink, but it's also a way to engage patients to help prevent surgical infections.